Chun Yuan Wu
Director of Finance/CFO at LAKESHORE BIOPHARMA CO., LTD
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hui Shao | M | 55 |
Liaoning Yisheng Biopharmaceutical Co., Ltd.
 Liaoning Yisheng Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Liaoning Yisheng Biopharmaceutical Co., Ltd. operates as biopharmaceutical company. It focuses on the research, development, manufacturing and sales and marketing of immunological and vaccine products. The company is headquartered in Beijing, China.
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 14 years |
| Ajit Shetty | M | 77 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Yi Chang | M | 66 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China.
Ernst & Young (China)
| 13 years |
| Viren Mehta | M | 74 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Shao Jing Tong | M | 53 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Zhong Kai Shi | M | 59 |
Liaoning Yisheng Biopharmaceutical Co., Ltd.
Liaoning Yisheng Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Liaoning Yisheng Biopharmaceutical Co., Ltd. operates as biopharmaceutical company. It focuses on the research, development, manufacturing and sales and marketing of immunological and vaccine products. The company is headquartered in Beijing, China.
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 4 years |
| Rachel Yu | F | 50 | - | |
| Han Zhong Li | M | 56 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Gang Li | M | 42 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Wing Yat Lui | M | 35 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Hong Gang Teng | M | 51 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 7 years |
| Yuan Liu | M | 37 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Zenaida Mojares | M | 65 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yi Zhang | M | 67 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 4 years |
| Min Zhu | M | - |
Washington State University
| 3 years |
| Megan Mae Roach | F | 44 |
Washington State University
| 6 years |
| Sommer Kleweno Walley | F | - |
Washington State University
| 6 years |
| Bo Tan | M | 51 | - | |
| Maher Khalil Mohammed Hassan | M | 54 |
Washington State University
| 4 years |
| Janelle Edington | F | 42 |
Washington State University
| 4 years |
| Hon Chung Pang | M | 50 |
Ernst & Young (China)
| 8 years |
| Ka Chi Yau | M | 66 |
Ernst & Young (China)
| 2 years |
| Bee Cheng Chan | F | 48 |
Ernst & Young (China)
| 3 years |
| Brock M. Vann | M | - |
Washington State University
| 2 years |
| Catherine Parkay | F | - |
Washington State University
| 4 years |
| Atit Chunhachatrachai | M | 41 |
Washington State University
| 4 years |
| Ka Wai Wong | M | 44 |
Ernst & Young (China)
| 2 years |
| Shi Kwan Ng | M | - |
Washington State University
| 4 years |
| Zhe Ming Lin | M | 45 |
Ernst & Young (China)
| 7 years |
| Brooke Randall | M | - |
Washington State University
| 4 years |
| Seng Hu Tan | M | 48 |
Washington State University
| 4 years |
| Ping Cheong Tso | M | 43 |
Ernst & Young (China)
| 1 years |
| Toby Bond | M | - |
Washington State University
| 4 years |
| Ka Keung Chan | M | 73 |
Ernst & Young (China)
| 14 years |
| Yi Su | F | 43 |
Ernst & Young (China)
| 7 years |
| Xiang Zhang | M | 40 |
Ernst & Young (China)
| 9 years |
| Xiao Ping Jin | M | 47 |
Washington State University
| 1 years |
| Jennifer Harris | F | - |
Washington State University
| 4 years |
| Melinda Wong | F | 49 |
Washington State University
| 4 years |
| Ryan O Malley | M | - |
Washington State University
| 4 years |
| Faith Zaslavsky | F | 49 |
Washington State University
| 4 years |
| Bradbury Alicia | F | - |
Washington State University
| 2 years |
| Wong Yu Shan Eugene | M | 54 |
Ernst & Young (China)
| 15 years |
| William Leigh | M | - |
Washington State University
| 5 years |
| Zhanxi Liu | M | 45 |
Ernst & Young (China)
| 5 years |
| Ying Liu | F | - |
Washington State University
| 2 years |
| Kai Deng | M | - |
Ernst & Young (China)
| 7 years |
| Jefff Pierce | M | - |
Washington State University
| 4 years |
| Li Qin Zhang | F | 45 |
Ernst & Young (China)
| 6 years |
| Min Xia He | F | 40 |
Ernst & Young (China)
| 8 years |
| Dong Xie | M | 44 |
Ernst & Young (China)
| 1 years |
| Andy Roed | M | - |
Washington State University
| 4 years |
| Christopher Slaughter | M | - |
Washington State University
| 4 years |
| Fredrik Amundsen | M | 48 |
Washington State University
| 3 years |
| Kong Wai Lee | M | 69 |
Ernst & Young (China)
| 29 years |
| Kwong Yeung To | M | 46 |
Ernst & Young (China)
| 9 years |
| Ting Yuk Wu | M | 69 |
Ernst & Young (China)
| 20 years |
| Yi Xin Huang | M | 57 |
Ernst & Young (China)
| 2 years |
| Yun Wei Tang | M | 79 |
Ernst & Young (China)
| 4 years |
| Yik Sang Li | M | 49 |
Ernst & Young (China)
| 4 years |
| Kevin Dix | M | - |
Washington State University
| 4 years |
| William F. Albert | M | - |
Washington State University
| 4 years |
| King On Wong | M | 71 |
Ernst & Young (China)
| 31 years |
| Anson Fatland | M | - |
Washington State University
| 3 years |
| Jun Feng Gao | M | 51 |
Ernst & Young (China)
| 1 years |
| Max M. McCain | M | - |
Washington State University
| 4 years |
| Adam Gelhausen | M | - |
Washington State University
| 3 years |
| Dan M. Leatzow | M | 47 |
Washington State University
| 3 years |
| Bruce Eaton | M | 70 |
Washington State University
| 11 years |
| Kelsey Schreck | F | - |
Washington State University
| 4 years |
| Keith Mayfield | M | - |
Washington State University
| 4 years |
| Tak Kwong Chan | M | 53 |
Ernst & Young (China)
| 10 years |
| King Sau Chan | M | 46 |
Ernst & Young (China)
| 8 years |
| Andreas Gottschling | M | 57 |
Washington State University
| 3 years |
| Zak Kennedy | M | - |
Washington State University
| 4 years |
| Bridgette Brady | F | - |
Washington State University
| 4 years |
| Eric Allen Irion | M | - |
Washington State University
| 4 years |
| Kristi Lenee Lord | F | - |
Washington State University
| 4 years |
| Ivan Kokeza | M | 63 |
Washington State University
| 2 years |
| Shilo Michelle Lockett | F | - |
Washington State University
| 5 years |
| Jia Guo Duan | M | 45 |
Ernst & Young (China)
| 2 years |
| Brian Joseph Lockett | M | - |
Washington State University
| 4 years |
| Stephen R. Westphal | M | - |
Washington State University
| 4 years |
| Kay Seng Goh | M | 50 |
Ernst & Young (China)
| - |
| R. Venkateswaran | M | - |
Washington State University
| 3 years |
| M. Grant Norton | M | - |
Washington State University
| 5 years |
| Richard Trotman | M | 42 |
Washington State University
| 4 years |
| Christopher Malde | M | - |
Washington State University
| 5 years |
| Ryan Peterson | M | - |
Washington State University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 47 | 52.81% |
| China | 42 | 47.19% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Chun Yuan Wu
- Personal Network
